Abstract Purpose of Review Coronavirus disease 2019 (COVID-19), caused by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a global health challenge. This …

Objectives “Long COVID”, a term coined by COVID-19 survivors, describes persistent or new
symptoms in a subset of patients who have recovered from acute illness. Globally, the …

Brain changes have been reported in the first weeks after SARS-CoV-2 infection. However,
limited literature exists about brain alterations in post-COVID syndrome, a condition …

The majority of people infected with SARS-CoV-2 fully recovered within a few weeks.
However, a considerable number of patients of different ages still suffer from long-lasting …

Background Neurologic manifestations are well-recognized features of coronavirus disease
2019 (COVID-19). However, the longitudinal association of biomarkers reflecting CNS …

Emerging evidence has suggested a close correlation between COVID-19 and
neurodegenerative disorders. However, whether there exists a causal association and the …

Objective Although complications and clinical symptoms of COVID-19 have been elucidated,
the prevalence of long-term sequelae of COVID-19 is less clear in previously hospitalized …

Background Dementia-like cognitive impairment is an increasingly reported complication of
SARS-CoV-2 infection. However, the underlying mechanisms responsible for this …

Background Clinical investigations have argued for long-term neurological manifestations in
both hospitalised and non-hospitalised COVID-19 patients. It is unclear whether long-term …

Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to
infection. Sepsis causes cerebral dysfunction in the short and long term and induces …